Recital 5, Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 Novembe…

In force

Because of the novelty, complexity and technical specificity of advanced therapy medicinal products, specially tailored and harmonised rules are needed to ensure the free movement of those products within the Community, and the effective operation of the internal market in the biotechnology sector.